The Test Results Demonstrate Significant Utility and Commercialization Potential for the Company’s Technology Ronkonkoma, New York, USA – TheNewswire September 7, 2021 – G6 Materials Corp. a technology company developing innovative graphene-based solutions today announced the results of the antimicrobial efficacy test on a prototype of G6’s proprietary graphene-based air purifier conducted by a US-based …
(TheNewswire)
The Test Results Demonstrate Significant Utility and Commercialization Potential for the Company’s Technology
Ronkonkoma, New York, USA – TheNewswire September 7, 2021 – G6 Materials Corp. (“G6” or the “Company”) (TSXV:GGG ) ( OTC:GPHBF), a technology company developing innovative graphene-based solutions today announced the results of the antimicrobial efficacy test on a prototype of G6’s proprietary graphene-based air purifier (the “ Lab Test ”) conducted by a US-based microbiological laboratory of The Intertek Group plc. The test showed that the concentration of pathogenic microorganisms present in the testing chamber was reduced by 99.9% ( “Test Results” ) over the duration of the experiment.
Two different pathogens were randomly chosen to be tested under each experiment, which were the E. coli bacteria and the Phi-X174 bacteriophage. The duration of the Lab Test was set to two hours. The Test Results were documented in an Efficacy Test Report (the “ Test Report ”) that has been received by the Company and summarized below:
| Organism Type: | ... |
Read Full Story: https://investingnews.com/news/nanoscience-investing/g6-materials-air-purifier-prototype-reduces-pathogenic-microorganisms-by-99.9-in-antimicrobial-efficacy-test/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.